DGX EBITDA | Quest Diagnostics Inc

Quest Diagnostics Inc (DGX) EBITDA

2026-06-30: Basis Reported; EBITDA $605M; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $546M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $531M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $528M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2007-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$605M	(m)	(m)	(m)	19.88%	$138.00M*	$597.00M*	(m)	(m)	$529.00M	$88.00M
2026-03-31	Reported	$546M	(m)	(m)	(m)	18.86%	$114.00M	$278.00M	(m)	(m)	$504.00M	$74.00M
2025-12-31	Reported	$531M	(m)	(m)	(m)	18.92%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$528M	(m)	(m)	(m)	18.75%	$144.00M*	$563.00M*	(m)	(m)	$501.00M	$77.00M
2025-06-30	Reported	$581M	(m)	(m)	(m)	21.04%	$108.00M*	$544.00M*	(m)	(m)	$486.00M	$97.00M
2025-03-31	Reported	$486M	(m)	(m)	(m)	18.33%	$117.00M	$314.00M	(m)	(m)	$476.00M	$59.00M
2024-12-31	Reported	$496M	(m)	(m)	(m)	18.92%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$455M	(m)	(m)	(m)	18.29%	$106.00M*	$356.00M*	(m)	(m)	$448.00M	$65.00M
2024-06-30	Reported	$472M	(m)	(m)	(m)	19.69%	$92.00M*	$360.00M*	(m)	(m)	$416.00M	$74.00M
2024-03-31	Reported	$416M	(m)	(m)	(m)	17.58%	$104.00M	$154.00M	(m)	(m)	$440.00M	$66.00M
2023-12-31	Reported	$376M	(m)	(m)	(m)	16.43%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$453M	(m)	(m)	(m)	19.74%	$105.00M*	$207.00M*	(m)	(m)	$380.00M	$68.00M
2023-06-30	Reported	$460M	(m)	(m)	(m)	19.67%	$104.00M*	$444.00M*	(m)	(m)	$416.00M	$75.00M
2023-03-31	Reported	$412M	(m)	(m)	(m)	17.67%	$127.00M	$94.00M	(m)	(m)	$439.00M	$65.00M
2022-12-31	Reported	$251M	(m)	(m)	(m)	10.76%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$500M	(m)	(m)	(m)	20.11%	$118.00M*	$502.00M*	(m)	(m)	$464.00M	$81.00M
2022-06-30	Reported	$495M	(m)	(m)	(m)	20.18%	$76.00M*	$402.00M*	(m)	(m)	$422.00M	$77.00M
2022-03-31	Reported	$619M	(m)	(m)	(m)	23.71%	$63.00M	$480.00M	(m)	(m)	$425.00M	$110.00M
2021-12-31	Reported	$642M	(m)	(m)	(m)	23.40%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$753M	(m)	(m)	(m)	27.14%	$89.00M*	$561.00M*	(m)	(m)	$427.00M	$153.00M
2021-06-30	Reported	$633M	(m)	(m)	(m)	24.82%	$84.00M*	$460.00M*	(m)	(m)	$429.00M	$177.00M
2021-03-31	Reported	$761M	(m)	(m)	(m)	27.98%	$86.00M	$731.00M	(m)	(m)	$407.00M	$153.00M
2020-12-31	Reported	$893M	(m)	(m)	(m)	29.75%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$807M	(m)	(m)	(m)	28.97%	$91.00M*	$862.00M*	(m)	(m)	$396.00M	$177.00M
2020-06-30	Reported	$372M	(m)	(m)	(m)	20.36%	$82.00M*	$355.00M*	(m)	(m)	$360.00M	$66.00M
2020-03-31	Reported	$260M	(m)	(m)	(m)	14.27%	$83.00M	$247.00M	(m)	(m)	$347.00M	$26.00M
2019-12-31	Reported	$445M	(m)	(m)	(m)	23.10%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$395M	(m)	(m)	(m)	20.19%	$96.00M*	$299.00M*	(m)	(m)	$362.00M	$62.00M
2019-06-30	Reported	$388M	(m)	(m)	(m)	19.87%	$85.00M*	$321.00M*	(m)	(m)	$362.00M	$63.00M
2019-03-31	Reported	$332M	(m)	(m)	(m)	17.56%	$47.00M	$275.00M	(m)	(m)	$384.00M	$50.00M
2018-12-31	Reported	$301M	(m)	(m)	(m)	16.37%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$381M	(m)	(m)	(m)	20.17%	$81.00M*	$402.00M*	(m)	(m)	$354.00M	$48.00M
2018-06-30	Reported	$382M	(m)	(m)	(m)	19.91%	$78.00M*	$323.00M*	(m)	(m)	$351.00M	$42.00M
2018-03-31	Reported	$346M	(m)	(m)	(m)	18.37%	$73.00M	$180.00M	(m)	(m)	$363.00M	$52.00M
2017-12-31	Reported	$342M	(m)	(m)	(m)	18.34%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$367M	(m)	(m)	(m)	19.77%	$63.00M*	$362.00M*	(m)	(m)	$348.00M	$92.00M
2017-06-30	Reported	$385M	(m)	(m)	(m)	20.65%	$65.00M*	$294.00M*	(m)	(m)	$358.00M	$94.00M
2017-03-31	Reported	$341M	(m)	(m)	(m)	18.77%	$42.00M	$196.00M	(m)	(m)	$355.00M	$78.00M
2016-12-31	Reported	$339M	(m)	(m)	(m)	21.73%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$385M	(m)	(m)	(m)	20.42%	$61.00M*	$301.00M*	(m)	(m)	$409.00M	$95.00M
2016-06-30	Reported	$483M	(m)	(m)	(m)	25.34%	$57.00M*	$311.00M*	(m)	(m)	$430.00M	$183.00M
2016-03-31	Reported	$319M	(m)	(m)	(m)	17.12%	$47.00M	$153.00M	(m)	(m)	$442.00M	$67.00M
2015-12-31	Reported	$313M	(m)	(m)	(m)	16.93%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$708M	(m)	(m)	(m)	37.66%	$52.00M*	$212.00M*	(m)	(m)	$402.00M	$239.00M
2015-06-30	Reported	$376M	(m)	(m)	(m)	19.53%	$61.00M*	$285.00M*	(m)	(m)	$429.00M	$78.00M
2015-03-31	Reported	$306M	(m)	(m)	(m)	16.64%	$56.00M	$52.00M	(m)	(m)	$419.00M	$42.00M
2014-12-31	Reported	$336M	(m)	(m)	(m)	17.84%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$335M	(m)	(m)	(m)	17.59%	$102.00M*	$271.00M*	(m)	(m)	$446.00M	$82.00M
2014-06-30	Reported	$343M	(m)	(m)	(m)	18.03%	$49.00M*	$280.00M*	(m)	(m)	$440.00M	$87.00M
2014-03-31	Reported	$283M	(m)	(m)	(m)	16.21%	$68.00M	$84.00M	(m)	(m)	$415.00M	$65.00M
2013-12-31	Reported	$342M	(m)	(m)	(m)	19.48%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	$758.00M*	$689.00M	$69.00M*	(m)	(m)	$50.00M*	$187.00M*	(m)	(m)	$423.00M	$245.00M
2013-06-30	Reported	$361.00M*	$289.00M	$72.00M*	(m)	(m)	$56.00M*	$208.00M*	(m)	(m)	$418.00M	$95.00M
2013-03-31	Reported	$297M	(m)	(m)	(m)	16.62%	$49.00M	$47.00M	(m)	(m)	$448.00M	$73.00M
2012-12-31	Reported	$336.91M	(m)	(m)	(m)	18.99%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	$375.89M*	$304.62M	$71.27M*	(m)	(m)	$44.91M*	$394.62M*	(m)	(m)	$416.85M	$103.98M
2012-06-30	Reported	$405.21M*	$333.35M	$71.86M*	(m)	(m)	$47.41M*	$250.87M*	(m)	(m)	$424.08M	$113.73M
2012-03-31	Reported	$369.99M	(m)	(m)	(m)	19.38%	$30.00M	$161.27M	(m)	(m)	$483.25M	$102.56M
2011-12-31	Reported	$388.7M	(m)	(m)	(m)	22.08%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$395.40M*	$322.05M	$73.35M*	(m)	(m)	$39.26M*	$337.64M*	(m)	(m)	$446.60M	$101.13M
2011-06-30	Reported	$389.57M*	$316.85M	$72.72M*	(m)	(m)	$39.63M*	$59.50M*	(m)	(m)	$462.79M	$105.76M
2011-03-31	Reported	$94.33M	(m)	(m)	(m)	5.18%	$38.99M	$160.58M	(m)	(m)	$447.86M	$49.23M
2010-12-31	Reported	$345.78M	(m)	(m)	(m)	20.16%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$401.00M*	$336.87M	$64.14M*	(m)	(m)	$47.44M*	$330.07M*	(m)	(m)	$426.56M	$102.90M
2010-06-30	Reported	$428.87M*	$365.89M	$62.97M*	(m)	(m)	$49.09M*	$209.17M*	(m)	(m)	$419.41M	$125.65M
2010-03-31	Reported	$361.9M	(m)	(m)	(m)	20.04%	$39.76M	$239.22M	(m)	(m)	$430.73M	$105.38M
2009-12-31	Reported	$393.42M	(m)	(m)	(m)	21.29%	(m)	(m)	(m)	(m)	(m)	(m)
2009-09-30	Reported	$411.89M*	$348.28M	$63.62M*	(m)	(m)	$41.04M*	$373.54M*	(m)	(m)	$441.57M	$125.14M
2009-06-30	Reported	$424.56M*	$359.38M	$65.19M*	(m)	(m)	$36.39M*	-$9.21M*	(m)	(m)	$448.76M	$123.53M
2009-03-31	Reported	$385.92M	(m)	(m)	(m)	21.35%	$39.61M	$272.76M	(m)	(m)	$424.30M	$110.19M
2008-12-31	Reported	$382.82M	(m)	(m)	(m)	21.26%	(m)	(m)	(m)	(m)	(m)	(m)
2008-09-30	Reported	$383.08M*	$316.94M	$66.14M*	(m)	(m)	(m)	$328.92M*	(m)	(m)	$428.18M	$100.64M
2008-06-30	Reported	(m)	$308.12M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$438.04M	$100.79M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$2.13B	(m)	(m)	(m)	19.27%	$527.00M	$1.89B	(m)	(m)	$1.97B	$314.00M
2024-12-31	Reported	$1.84B	(m)	(m)	(m)	18.63%	$425.00M	$1.33B	(m)	(m)	$1.77B	$273.00M
2023-12-31	Reported	$1.7B	(m)	(m)	(m)	18.39%	$408.00M	$1.27B	(m)	(m)	$1.64B	$248.00M
2022-12-31	Reported	$1.87B	(m)	(m)	(m)	18.87%	$404.00M	$1.72B	(m)	(m)	$1.87B	$264.00M
2021-12-31	Reported	$2.79B	(m)	(m)	(m)	25.85%	$403.00M	$2.23B	(m)	(m)	$1.73B	$597.00M
2020-12-31	Reported	$2.33B	(m)	(m)	(m)	24.71%	$418.00M	$2.00B	(m)	(m)	$1.55B	$460.00M
2019-12-31	Reported	$1.56B	(m)	(m)	(m)	20.19%	$400.00M	$1.24B	(m)	(m)	$1.46B	$247.00M
2018-12-31	Reported	$1.41B	(m)	(m)	(m)	18.72%	$383.00M	$1.20B	(m)	(m)	$1.42B	$182.00M
2017-12-31	Reported	$1.44B	(m)	(m)	(m)	19.39%	$252.00M	$1.18B	(m)	(m)	$1.44B	$241.00M
2016-12-31	Reported	$1.53B	(m)	(m)	(m)	21.15%	$293.00M	$1.12B	(m)	(m)	$1.38B	$429.00M
2015-12-31	Reported	$1.7B	(m)	(m)	(m)	22.73%	$263.00M	$821.00M	(m)	(m)	$1.68B	$373.00M
2014-12-31	Reported	$1.3B	(m)	(m)	(m)	17.44%	$308.00M	$944.00M	(m)	(m)	$1.73B	$262.00M
2013-12-31	Reported	$1.76B	(m)	(m)	(m)	24.60%	$231.00M	$652.00M	(m)	(m)	$1.70B	$500.00M
2012-12-31	Reported	$1.49B	(m)	(m)	(m)	20.15%	$182.00M	$1.19B	(m)	(m)	$1.75B	$402.00M
2011-12-31	Reported	$1.27B	(m)	(m)	(m)	17.15%	$161.00M	$895.00M	(m)	(m)	$1.74B	$355.00M
2010-12-31	Reported	$1.54B	(m)	(m)	(m)	21.18%	$205.40M	$1.12B	(m)	(m)	$1.66B	$430.13M
2009-12-31	Reported	$1.62B	(m)	(m)	(m)	21.67%	$166.93M	$997.42M	(m)	(m)	$1.75B	$460.47M
2008-12-31	Reported	$1.49B	(m)	(m)	(m)	20.51%	$212.68M	$1.06B	(m)	(m)	$1.74B	$386.77M
2007-12-31	Reported	$1.33B	(m)	(m)	(m)	19.82%	$219.10M	$926.92M	(m)	(m)	$1.61B	$358.57M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
LABCORP HOLDINGS INC. (LH)	United States	$25.060B	22.60
Guardant Health, Inc. (GH)	United States	$23.675B	-12.65
Caris Life Sciences, Inc. (CAI)	United States	$9.119B	47.87
RadNet, Inc. (RDNT)	United States	$5.611B	-229.65
GRAIL, Inc. (GRAL)	United States	$5.591B	-7.78
VERACYTE, INC. (VCYT)	United States	$3.904B	41.21
Celcuity Inc. (CELC)	United States	$3.887B	-22.62
CareDx, Inc. (CDNA)	United States	$3.174B	13.21
Fortrea Holdings Inc. (FTRE)	United States	$1.903B	-19.43
Personalis, Inc. (PSNL)	United States	$1.769B	-13.30